ADIL CIK: 1513525

Adial Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.3
FY22:
−10.9
FY23:
−6.89
FY24:
−8.28
FY25:
−7.80
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−10.9
FY23:
–
FY24:
−3.82
FY25:
−7.80
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.5
FY22:
−10.8
FY23:
−7.00
FY24:
−13.2
FY25:
−7.98
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.4
FY22:
−12.7
FY23:
−5.12
FY24:
−13.2
FY25:
−7.98

All amounts in millions USD Data sources:SEC EDGARTwelve Data